Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Kathe E. Douglas"'
Autor:
Rebecca L. Green, Kathe E. Douglas, S. Patel, Dominic T. Moore, Juneko E. Grilley Olson, Gaorav P. Gupta, Siddharth Sheth, Colette J. Shen, Jared Weiss, Dan Goldin, Bhishamjit S. Chera
Publikováno v:
Cancer. 127:4447-4454
Background Adavosertib (AZD1775) is an inhibitor of the Wee1 kinase. The authors conducted a phase 1b trial to evaluate the safety of adavosertib in combination with definitive chemoradiotherapy for patients with newly diagnosed, intermediate-risk/hi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f6a967dd2be14e8bf69f79b7ffce18b
https://doi.org/10.1002/cncr.33789
https://doi.org/10.1002/cncr.33789
Autor:
Nirav Dhruva, Carrie B. Lee, Jared Weiss, Kathe E. Douglas, Allison M. Deal, S. Patel, Joan H Schiller, David E. Gerber, Chad V. Pecot
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, Vol 11 (2021)
BackgroundInduction with four cycles of platinum-based chemotherapy was the standard of care for metastatic non-small cell lung cancer (NSCLC) until the approval of immune checkpoint blockade (ICB) in the first-line setting. Switch maintenance therap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be9e5b0f6addbd5d2f3b61847ba24fd6
https://pubmed.ncbi.nlm.nih.gov/33912470
https://pubmed.ncbi.nlm.nih.gov/33912470